196 related articles for article (PubMed ID: 16544426)
1. Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.
Lindsay DS; Kaur T; Mitchell SM; Goodwin DG; Strobl J; Dubey JP
J Parasitol; 2005 Dec; 91(6):1488-90. PubMed ID: 16544426
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.
Mitchell SM; Zajac AM; Davis WL; Lindsay DS
J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
Alves CF; Vitor RW
Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
[TBL] [Abstract][Full Text] [Related]
8. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
[TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
[TBL] [Abstract][Full Text] [Related]
11. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of mice with Neospora caninum: response to oral challenge with Toxoplasma gondii oocysts.
Lindsay DS; Lenz SD; Dykstra CC; Blagburn BL; Dubey JP
J Parasitol; 1998 Apr; 84(2):311-5. PubMed ID: 9576504
[TBL] [Abstract][Full Text] [Related]
14. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
[TBL] [Abstract][Full Text] [Related]
15. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918
[TBL] [Abstract][Full Text] [Related]
16. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii.
Suzuki Y; Yang Q; Remington JS
J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050
[TBL] [Abstract][Full Text] [Related]
17. Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice.
Dubey JP; Shen SK; Kwok OC; Frenkel JK
J Parasitol; 1999 Aug; 85(4):657-62. PubMed ID: 10461945
[TBL] [Abstract][Full Text] [Related]
18. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
Khan AA; Lambert LH; Remington JS; Araujo FG
Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
[TBL] [Abstract][Full Text] [Related]
19. Detection of Toxoplasma gondii by polymerase chain reaction in sera of acutely infected mice.
Hafid J; Guichard D; Flori P; Bourlet T; Raberin H; Genin C; Sung RT
J Parasitol; 2000 Aug; 86(4):857-9. PubMed ID: 10958473
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
